{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:58:04Z","timestamp":1789138684860,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10528-025-11103-5","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T12:15:37Z","timestamp":1745237737000},"page":"1725-1743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ceritinib Reduces Transendothelial Invasion of Non-small Cell Lung Cancer Cells by Restoring Claudin-10 and Suppressing VEGF-A Signaling"],"prefix":"10.1007","volume":"64","author":[{"given":"Xin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"4","key":"11103_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12079-016-0352-8","volume":"10","author":"CS Abhinand","year":"2016","unstructured":"Abhinand CS, Raju R, Soumya SJ, Arya PS, Sudhakaran PR (2016) VEGF-A\/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J Cell Commun Signal 10(4):347\u2013354","journal-title":"J Cell Commun Signal"},{"key":"11103_CR2","doi-asserted-by":"publisher","first-page":"6564585","DOI":"10.1155\/2021\/6564585","volume":"2021","author":"A Alahmari","year":"2021","unstructured":"Alahmari A (2021) Blood-brain barrier overview: structural and functional correlation. Neural Plast 2021:6564585","journal-title":"Neural Plast"},{"key":"11103_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.crad.2022.09.134","volume":"78","author":"N Chakrabarty","year":"2023","unstructured":"Chakrabarty N, Mahajan A, Patil V, Noronha V, Prabhash K (2023) Imaging of brain metastasis in non-small-cell lung cancer: indications, protocols, diagnosis, post-therapy imaging, and implications regarding management. Clin Radiol 78:175\u2013186","journal-title":"Clin Radiol"},{"key":"11103_CR4","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-21-1838","volume":"28","author":"LQM Chow","year":"2022","unstructured":"Chow LQM, Barlesi F, Bertino EM, van den Bent MJ, Wakelee HA, Wen PY et al (2022) ASCEND-7: efficacy and safety of ceritinib treatment in patients with ALK-positive non-Small cell lung cancer metastatic to the brain and\/or leptomeninges. Clin Cancer Res 28:2506\u20132516","journal-title":"Clin Cancer Res"},{"key":"11103_CR5","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s40265-014-0251-3","volume":"74","author":"S Dhillon","year":"2014","unstructured":"Dhillon S, Clark M (2014) Ceritinib: first global approval. Drugs 74:1285\u20131291","journal-title":"Drugs"},{"key":"11103_CR6","first-page":"1789","volume":"6","author":"Y Fan","year":"2013","unstructured":"Fan Y, Huang Z, Fang L, Miu L, Lin N, Gong L et al (2013) Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients. Onco Targets Ther 6:1789\u20131803","journal-title":"Onco Targets Ther"},{"key":"11103_CR7","first-page":"331","volume":"21","author":"X Feng","year":"2021","unstructured":"Feng X, Xu ES (2021) Alectinib and lorlatinib function by modulating EMT-related proteins and MMPs in NSCLC metastasis. Bosn J Basic Med Sci 21:331\u2013338","journal-title":"Bosn J Basic Med Sci"},{"key":"11103_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030742","author":"S Fuladi","year":"2020","unstructured":"Fuladi S, Jannat RW, Shen L, Weber CR, Khalili-Araghi F (2020) Computational modeling of claudin structure and function. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21030742","journal-title":"Int J Mol Sci."},{"key":"11103_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jconrel.2018.07.016","volume":"285","author":"HJ Galla","year":"2018","unstructured":"Galla HJ (2018) Monocultures of primary porcine brain capillary endothelial cells: still a functional in vitro model for the blood-brain-barrier. J Control Release 285:172\u2013177","journal-title":"J Control Release"},{"key":"11103_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1083\/jcb.147.6.1351","volume":"147","author":"M Itoh","year":"1999","unstructured":"Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S (1999) Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147:1351\u20131363","journal-title":"J Cell Biol"},{"key":"11103_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11060-019-03188-x","volume":"143","author":"SA Jassam","year":"2019","unstructured":"Jassam SA, Maherally Z, Ashkan K, Pilkington GJ, Fillmore HL (2019) Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood-brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis. J Neurooncol 143:405\u2013415","journal-title":"J Neurooncol"},{"key":"11103_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L (2020) A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluid Barrier CNS 17:69","journal-title":"Fluid Barrier CNS"},{"issue":"7","key":"11103_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006502","volume":"2","author":"S Koch","year":"2012","unstructured":"Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2(7):a006502","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"11103_CR14","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nchembio.2489","volume":"13","author":"BM Kuenzi","year":"2017","unstructured":"Kuenzi BM, Remsing Rix LL, Stewart PA, Fang B, Kinose F, Bryant AT et al (2017) Polypharmacology-based ceritinib repurposing using integrated functional proteomics. Nat Chem Biol 13(12):1222\u20131231","journal-title":"Nat Chem Biol"},{"issue":"4","key":"11103_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1083\/jcb.200602080","volume":"174","author":"MG Lampugnani","year":"2006","unstructured":"Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E (2006) Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 174(4):593\u2013604","journal-title":"J Cell Biol"},{"key":"11103_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115891","volume":"169","author":"Y Li","year":"2023","unstructured":"Li Y, Yan B, He S (2023) Advances and challenges in the treatment of lung cancer. Biomed Pharmacother 169:115891","journal-title":"Biomed Pharmacother"},{"key":"11103_CR17","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.2147\/DDDT.S250904","volume":"14","author":"J Liu","year":"2020","unstructured":"Liu J, Chen L, Zhang X, Pan L, Jiang L (2020) The Protective effects of juglanin in cerebral ischemia reduce blood-brain barrier permeability via inhibition of VEGF\/VEGFR2 signaling. Drug des Devel Ther 14:3165\u20133175","journal-title":"Drug des Devel Ther"},{"key":"11103_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ar.22878","volume":"297","author":"Z Miao","year":"2014","unstructured":"Miao Z, Dong Y, Fang W, Shang D, Liu D, Zhang K et al (2014) VEGF increases paracellular permeability in brain endothelial cells via upregulation of EphA2. Anat Rec (Hoboken) 297:964\u2013972","journal-title":"Anat Rec (Hoboken)"},{"key":"11103_CR19","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/curroncol29030150","volume":"29","author":"H Mithoowani","year":"2022","unstructured":"Mithoowani H, Febbraro M (2022) Non-small-cell lung cancer in 2022: a review for general practitioners in oncology. Curr Oncol 29:1828\u20131839","journal-title":"Curr Oncol"},{"key":"11103_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ctrv.2017.03.006","volume":"55","author":"TSK Mok","year":"2017","unstructured":"Mok TSK, Crino L, Felip E, Salgia R, De Pas T, Tan DSW et al (2017) The accelerated path of ceritinib: Translating pre-clinical development into clinical efficacy. Cancer Treat Rev 55:181\u2013189","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"11103_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/01.CIR.97.1.99","volume":"97","author":"T Murohara","year":"1998","unstructured":"Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM (1998) Vascular endothelial growth factor\/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97(1):99\u2013107","journal-title":"Circulation"},{"issue":"2","key":"11103_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ph17020197","volume":"17","author":"KZ Myint","year":"2024","unstructured":"Myint KZ, Balasubramanian B, Venkatraman S, Phimsen S, Sripramote S, Jantra J et al (2024) Therapeutic implications of ceritinib in cholangiocarcinoma beyond ALK expression and mutation. Pharmaceuticals (Basel) 17(2):197","journal-title":"Pharmaceuticals (Basel)"},{"key":"11103_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.tcb.2020.08.004","volume":"30","author":"T Otani","year":"2020","unstructured":"Otani T, Furuse M (2020) Tight junction structure and function revisited. Trends Cell Biol 30:805\u2013817","journal-title":"Trends Cell Biol"},{"issue":"1","key":"11103_CR24","doi-asserted-by":"publisher","first-page":"1973197","DOI":"10.1080\/2162402X.2021.1973197","volume":"10","author":"A Petrazzuolo","year":"2021","unstructured":"Petrazzuolo A, Perez-Lanzon M, Liu P, Maiuri MC, Kroemer G (2021) Crizotinib and ceritinib trigger immunogenic cell death via on-target effects. Oncoimmunology 10(1):1973197","journal-title":"Oncoimmunology"},{"key":"11103_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jtho.2015.11.014","volume":"11","author":"M Schuler","year":"2016","unstructured":"Schuler M, Wu YL, Hirsh V, O\u2019Byrne K, Yamamoto N, Mok T et al (2016) First-line Afatinib versus chemotherapy in patients with non-small cell lung cancer and common epidermal growth factor receptor gene mutations and brain metastases. J Thorac Oncol 11:380\u2013390","journal-title":"J Thorac Oncol"},{"key":"11103_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S1470-2045(17)30339-X","volume":"18","author":"AT Shaw","year":"2017","unstructured":"Shaw AT, Kim TM, Crino L, Gridelli C, Kiura K, Liu G et al (2017) Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol 18:874\u2013886","journal-title":"Lancet Oncol"},{"issue":"10","key":"11103_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","volume":"17","author":"M Simons","year":"2016","unstructured":"Simons M, Gordon E, Claesson-Welsh L (2016) Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol 17(10):611\u2013625","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11103_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/toxsci\/kfr349","volume":"126","author":"E Sipos","year":"2012","unstructured":"Sipos E, Chen L, Andras IE, Wrobel J, Zhang B, Pu H et al (2012) Proinflammatory adhesion molecules facilitate polychlorinated biphenyl-mediated enhancement of brain metastasis formation. Toxicol Sci 126:362\u2013371","journal-title":"Toxicol Sci"},{"key":"11103_CR29","doi-asserted-by":"publisher","first-page":"1908109","DOI":"10.1080\/21688370.2021.1908109","volume":"9","author":"K Sugimoto","year":"2021","unstructured":"Sugimoto K, Chiba H (2021) The claudin-transcription factor signaling pathway. Tissue Barriers 9:1908109","journal-title":"Tissue Barriers"},{"key":"11103_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/pin.13349","volume":"73","author":"A Takasawa","year":"2023","unstructured":"Takasawa A, Takasawa K, Murata M, Osanai M, Sawada N (2023) Emerging roles of transmembrane-type tight junction proteins in cancers. Pathol Int 73:331\u2013340","journal-title":"Pathol Int"},{"key":"11103_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.691771","volume":"11","author":"K Wang","year":"2021","unstructured":"Wang K, Dong S, Higazy D, Jin L, Zou Q, Chen H et al (2021) Inflammatory environment promotes the adhesion of tumor cells to brain microvascular endothelial cells. Front Oncol 11:691771","journal-title":"Front Oncol"},{"key":"11103_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41419-021-04004-z","volume":"12","author":"D Wu","year":"2021","unstructured":"Wu D, Deng S, Li L, Liu T, Zhang T, Li J et al (2021) TGF-beta1-mediated exosomal lnc-MMP2-2 increases blood-brain barrier permeability via the miRNA-1207-5p\/EPB41L5 axis to promote non-small cell lung cancer brain metastasis. Cell Death Dis 12:721","journal-title":"Cell Death Dis"},{"issue":"7","key":"11103_CR33","first-page":"5905","volume":"16","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li C, Yang S, Zhang Z, Bai X, Tang H, Huang J (2024) Cepharanthine maintains integrity of the blood-brain barrier (BBB) in stroke via the VEGF\/VEGFR2\/ZO-1 signaling pathway. Aging (Albany NY) 16(7):5905\u20135915","journal-title":"Aging (Albany NY)"},{"key":"11103_CR34","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","volume":"163","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV (2015) Establishment and dysfunction of the blood-brain barrier. Cell 163:1064\u20131078","journal-title":"Cell"},{"issue":"9","key":"11103_CR35","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.21873\/anticanres.16580","volume":"43","author":"X Zhuang","year":"2023","unstructured":"Zhuang X, Ji W, Fang Z et al (2023) Claudin-10 in the blood brain barrier function of cerebral endothelial cells and transendothelial invasion of breast cancer cells. Anticancer Res 43(9):3923\u20133934","journal-title":"Anticancer Res"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11103-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11103-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11103-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:02:35Z","timestamp":1776434555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11103-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["11103"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11103-5","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}